
Angel Medical Systems Stock
Angel Medical Systems is a medical company that offers AngelMed Guardian an implantable cardiac monitoring and alerting system.
Sign up today and learn more about Angel Medical Systems Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Angel Medical Systems Stock
Angel Medical Systems develops cardiac medical devices for patients in Brazil. It offers AngelMed Guardian system, an implantable cardiac monitoring and alerting system, which detects and warns patients of acute episodes of cardiac ischemia related to the progression of coronary artery disease and thrombotic coronary occlusion caused by vulnerable plaque ruptures. The company’s AngelMed Guardian System components include an internal implantable device that is designed to detect, analyze, and record crucial heart signal data; vibrate to alert patients of cardiac events, and track ST deviations vs. heart rate for up to six months. Its AngelMed Guardian System components also include an external telemetry device; and a programmer, which aids physicians in evaluating heart signals. The company was incorporated in 2001 and is based in Shrewsbury, New Jersey.
Funding History
April 2013 | $17.5M |
---|---|
December 2014 | $10.2M |
March 2019 | $10.0M |
August 2021 | $3.9M |
Management
Founder & Chairman
Robert Fischell
Board Director
Kadir Kadhiresan
Chief Executive Officer
Gordie Nye
Boards of Directors
Robert J. Flanagan
Press
prnewswire - Nov, 5 2021
Angel Medical Systems Announces Mike Gillem as Chief Commercial Officernews - Jul, 24 2020
Angel Medical Systems Appoints New CEOmassdevice - Apr, 2 2019
Angel Medical Systems clears bankruptcy, raises $10mmassdevice - Jan, 11 2019
Angel Medical Systems wins approval for Chapter 11 bankruptcy planmassdevice - Apr, 21 2018
FDA approves Angel Medical System’s AngelMed Guardian cardiac monitorfiercebiotech - Apr, 21 2018
FDA approves heart monitor unanimously rejected by expert panel in 2016njbiz - May, 16 2017
EDA opens applications for 2017 Technology Business Tax Certificate Transfer Programmassdevice - Feb, 10 2016
Cartiva, Angel Medical win FDA PMA review datesmassdevice - Sep, 29 2015
ViewRay closes $27m private placementmassdevice - Sep, 29 2015
Treating epilepsy is harder than you thinkmassdevice - Sep, 29 2015
Allergan CEO Pyott steps down from Edwards Lifesciences board | Personnel MovesEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase